Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE Innovation Scorecards

NICE has announced that hospital and primary care trusts will be rated on a publicly available innovation scorecard measuring which trusts are adopting the latest NICE-approved treatments and drugs most quickly.

It is hoped that making such information available will ensure a more consistent response to national guidance, reduce geographical variations and bring an end to 'postcode prescribing'.

Health Minister Paul Burstow has stated that trusts will be expected to explain why NICE-approved treatments are not available in their area where that appears to be the case.

Action: Clinicians should be aware of this proposed scorecard system. Patients may raise questions with individual clinicians based on the reported scorecard performance in their area.

Share 'NICE Innovation Scorecards' on Email Share 'NICE Innovation Scorecards' on Delicious Share 'NICE Innovation Scorecards' on Digg Share 'NICE Innovation Scorecards' on Facebook Share 'NICE Innovation Scorecards' on Google+ Share 'NICE Innovation Scorecards' on reddit Share 'NICE Innovation Scorecards' on StumbleUpon Share 'NICE Innovation Scorecards' on Twitter

atomic-wealth

One Comments to “NICE Innovation Scorecards”

  1. […] hot topic section contains a summary of the evidence that supports the recent advice to restrict the daily dose of simvastatin when used in conjunction with amlodipine or diltiazem. It […]

    Pingback by Drug Safety Update – October 2012 | Prescribing Advice For GPs — October 31, 2012 #
    Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,515 spam comments.

atomic-wealth
fond-illness
summer